Apoferritin nanocages loading mertansine enable effective eradiation of cancer stem-like cells in vitro | |
Tan, Tao1; Wang, Yuqi1; Wang, Hong2,3; Cao, Haiqiang2,3; Wang, Zhiwan2,3; Wang, Jing2,3; Li, Jie2,3; Li, Yaping2,3; Zhang, Zhiwen2,3; Wang, Siling1 | |
刊名 | INTERNATIONAL JOURNAL OF PHARMACEUTICS |
2018-12-20 | |
卷号 | 553期号:1-2页码:201-209 |
关键词 | Apoferritin Mertansine Cancer stem cells Breast cancer Nanocages Drug delivery |
ISSN号 | 0378-5173 |
DOI | 10.1016/j.ijpharm.2018.10.038 |
文献子类 | Article |
英文摘要 | Cancer stem-like cells (CSCs) are proposed to be responsible for tumor metastasis, resistance and relapse after therapy, but are unable to be eliminated by many current therapies. Herein, we report that the apoferritin nanocages loading cytotoxic mertansine (M-AFN) can significantly improve their uptake in CSCs-enriched tumorspheres and effectively eradicate CSCs in tumorspheres for anticancer therapy. M-AFN were uniformly nanocage structures with the mean diameter of 11.26 +/- 2.58 nm and the loading capacity of 0.62%. In the CSCs-enriched tumorsphere model, M-AFN could be preferentially internalized by tumorsphere cells and the average half-inhibitory concentration (IC50) of M-AFN was obviously reduced by 5.46-fold when comparing to the parent 4T1 breast cancer cells. Moreover, both the already existing tumorspheres and the formation of secondary tumorspheres were drastically disrupted by M-AFN, but barely impacted by mertansine alone. The flow cytometer analysis showed the CSCs fractions in tumorspheres were considerably reduced by the M-AFN treatment. Therefore, the apoferritin nanocages represent an encouraging nanoplatform to eradicate CSCs for effective anticancer therapy. |
资助项目 | National Basic Research Program of China[2015CB932103] ; National Natural Science Foundation of China[31771092] ; National Natural Science Foundation of China[81521005] ; National Natural Science Foundation of China[81690265] ; Youth Innovation Promotion Association of Chinese Academy of Sciences[00000000] |
WOS关键词 | FERRITIN NANOCAGES ; LUNG METASTASIS ; TUMOR ; DELIVERY ; THERAPY ; NANOPARTICLES ; NANOMEDICINES ; DOXORUBICIN ; GLIOBLASTOMA ; FORMULATION |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | ELSEVIER SCIENCE BV |
WOS记录号 | WOS:000451020300019 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/279465] |
专题 | 药物制剂研究中心 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
通讯作者 | Zhang, Zhiwen; Wang, Siling |
作者单位 | 1.Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Liaoning, Peoples R China; 2.Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; 3.Chinese Acad Sci, Ctr Pharmaceut, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Tan, Tao,Wang, Yuqi,Wang, Hong,et al. Apoferritin nanocages loading mertansine enable effective eradiation of cancer stem-like cells in vitro[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS,2018,553(1-2):201-209. |
APA | Tan, Tao.,Wang, Yuqi.,Wang, Hong.,Cao, Haiqiang.,Wang, Zhiwan.,...&Wang, Siling.(2018).Apoferritin nanocages loading mertansine enable effective eradiation of cancer stem-like cells in vitro.INTERNATIONAL JOURNAL OF PHARMACEUTICS,553(1-2),201-209. |
MLA | Tan, Tao,et al."Apoferritin nanocages loading mertansine enable effective eradiation of cancer stem-like cells in vitro".INTERNATIONAL JOURNAL OF PHARMACEUTICS 553.1-2(2018):201-209. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论